J. Shingles

Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans

Albert-László Barabási, Marc Vidal, César A Hidalgo, 2007, Nature Biotechnology.

A compendium of Caenorhabditis elegans regulatory transcription factors: a resource for mapping transcription regulatory networks

Christian A. Grove, B. Deplancke, C. Grove, 2005, Genome Biology.

Meloidogyne incognita: molecular and biochemical characterisation of a cathepsin L cysteine proteinase and the effect on parasitism following RNAi.

P. Urwin, J. Shingles, H. Atkinson, 2007, Experimental parasitology.

Insight into transcription factor gene duplication from Caenorhabditis elegans Promoterome-driven expression patterns

Christian A. Grove, M. Vidal, D. Dupuy, 2007, BMC Genomics.

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

E. Montserrat, N. Villamor, A. Pettitt, 2013, Leukemia.

Chronic lymphocytic leukaemia (CLL) and CLL‐type monoclonal B‐cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing

Jane Shingles, J. Shingles, R. de Tute, 2010, Cytometry. Part B, Clinical cytometry.

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.

A. Schuh, D. Cairns, J. Shingles, 2023, The Lancet. Oncology.

A compendium of Caenorhabditis elegans regulatory transcription factors: a resource for mapping transcription regulatory networks

Christian A. Grove, B. Deplancke, I. Hope, 2005, Genome biology.